Raymond James Financial Services Advisors, Inc. Editas Medicine, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 60,894 shares of EDIT stock, worth $113,871. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,894
Previous 65,097
6.46%
Holding current value
$113,871
Previous $304,000
31.91%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding EDIT
# of Institutions
218Shares Held
48.4MCall Options Held
436KPut Options Held
324K-
Black Rock Inc. New York, NY7.78MShares$14.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.47MShares$14 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.66MShares$4.97 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL2.6MShares$4.86 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.94MShares$3.63 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $129M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...